Haematologist Kylie Chimes explores infection risk in multiple myeloma, with a focus on how the disease and its treatments affect the immune system and what can be done to reduce infections.
This session explains why people with myeloma are immunocompromised, outlines common strategies used in clinical practice to lower infection risk—including vaccinations, antibiotics, and immunoglobulin (Ig) replacement—and examines how Ig therapy is currently used across Australia and internationally. Dr Chimes also discusses the evidence behind Ig replacement, highlights gaps in current research, and provides an overview of ongoing clinical trials aiming to improve guidance on when and how Ig should be used in supportive care.
Keep watching
Watch our other webinars
-
Blood, bones and the tip of the iceberg: Myeloma markers and monitoring
Professor Simon Harrison provides a clear overview of how myeloma is diagnosed, monitored and assessed over time.
-
Common myeloma side effects and strategies to improve quality of life
Haematologist Joy Ho discusses common side effects of myeloma and its treatments, with practical strategies to support quality of life. The presentation covers peripheral neuropathy,…
-
Myeloma Carer’s toolkit
Myeloma Specialist Nurse Lucy Murphy shares practical guidance for people caring for someone with myeloma. She discusses the carer’s role, informed decision-making, practical support, communication,…
-
Bi-specific and tri-specific T cell engagers for the treatment of myeloma
Professor Hang Quach explains how bispecific and trispecific T-cell engagers are changing multiple myeloma treatment. He discusses how these therapies work, current and emerging treatment…
-
Travel and myeloma- National myeloma month 2022
Senior Myeloma Specialist Nurse Jo discusses travel and myeloma, including planning with your treating team, medications, medical letters, vaccinations, travel insurance, infection precautions and practical…
-
National myeloma update 2025
Prof. Miles Prince’s 2025 myeloma update: from chemo to cutting-edge immunotherapies like CAR-T & bispecifics. Learn about new treatments, access, and the future of care
-
Exploring impacts of new technology
Associate Professor Edwin Hawkins explores how myeloma cells interact with the bone marrow microenvironment and evade immune responses. Using advanced imaging and spatial transcriptomics, this…
-
Supportive care and mental health and wellbeing
Psychologist Natalie Tucky discusses mental health, supportive care, self-advocacy, and wellbeing for people living with myeloma and precursor conditions.
-
Your immune system- Supporting immune function
Learn how multiple myeloma affects the immune system, why infection risk is higher, and how treatments like immunoglobulin replacement, vaccines, and antibiotics are used to…
-
Autologous stem cell transplant
Clinical Nurse Consultant Jenny Paul explains the autologous stem cell transplant process for myeloma, covering mobilisation, chemotherapy, reinfusion, side-effect management, and long-term recovery in a…
Connect with us
Stay informed with the latest myeloma research, treatment updates, and support resources. We offer tailored newsletters for both patients and healthcare professionals with relevant information and community updates.
